A role for NF-κB in chromaffin neoplastic disease progression has been suggested in a study showing that inhibition of NF-κB with triptolide decreases the metastasising capability of phaeochromocytoma cells in a murine model of malignant PPGL dissemination in vivo [51]. Here, NFKB1 is linked to glycogen storage disease VI.